about
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Constr...
Read More
37.31
0.81
(2.22%)
473.1K
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bullish
Neurogene Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..